Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion
Product Description
Mana Pharma
-
ES
-
2024On CPHI since
-
2Certificates
-
25 - 49Employees
Company types
Primary activities
Categories
Specifications
Mana Pharma
-
ES
-
2024On CPHI since
-
2Certificates
-
25 - 49Employees
Company types
Primary activities
More Products from Mana Pharma (7)
-
Product Edrophonium bromide
Cognitive & Mental Function; Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents, including synthetic ones, in prolonged apnoea and in any syndrome involving any syndrome involving atony of the striated or smooth fibre musculature striated or smooth fibre ... -
Product Procainamide Hydrochloride
Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies. -
Product UROKINASES SYNER MEDICA 500.000
Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae - extensive acute proximal deep vein thrombosis - acute massive pulmonary embolism - acute occlusive peripheral arterial disease with limb threatening ischemia -
Product ANTICUDE
Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents and synthetic ones, in prolonged apnea and in any syndrome involving atony of the striated or smooth fibre musculature. It is also used in the diagnosis and treatment of myasthenia gravis and to aid in th... -
Product BIOCORYL 100 MG/ML
Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies. -
Product Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion
Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemi... -
Product Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion
Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemia
Mana Pharma resources (2)
-
News Mana Pharma Positioning and differentiation in the sector
Since the end of 2020, Mana Pharma, S.L. has played a key role in the distribution of Medicines for Special Situations (MSS) in Spain, contributing, in agreement with the Health Authorities, to alleviate the lack of supply of medicines that occur in our country.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance